Literature DB >> 33681216

Regulation of the Migration of Distinct Dendritic Cell Subsets.

Meng Feng1, Shuping Zhou1, Yong Yu1, Qinghong Su1, Xiaofan Li1, Wei Lin1.   

Abstract

Dendritic cells (DCs), a class of antigen-presenting cells, are widely present in tissues and apparatuses of the body, and their ability to migrate is key for the initiation of immune activation and tolerogenic immune responses. The importance of DCs migration for their differentiation, phenotypic states, and immunologic functions has attracted widespread attention. In this review, we discussed and compared the chemokines, membrane molecules, and migration patterns of conventional DCs, plasmocytoid DCs, and recently proposed DC subgroups. We also review the promoters and inhibitors that affect DCs migration, including the hypoxia microenvironment, tumor microenvironment, inflammatory factors, and pathogenic microorganisms. Further understanding of the migration mechanisms and regulatory factors of DC subgroups provides new insights for the treatment of diseases, such as infection, tumors, and vaccine preparation.
Copyright © 2021 Feng, Zhou, Yu, Su, Li and Lin.

Entities:  

Keywords:  adhesion molecules; chemokines; conventional dendritic cells; dendritic cells; migration; plasmacytoid dendritic cells

Year:  2021        PMID: 33681216      PMCID: PMC7933215          DOI: 10.3389/fcell.2021.635221

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  6 in total

1.  EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22.

Authors:  Aparna Jorapur; Lisa A Marshall; Scott Jacobson; Mengshu Xu; Sachie Marubayashi; Mikhail Zibinsky; Dennis X Hu; Omar Robles; Jeffrey J Jackson; Valentin Baloche; Pierre Busson; David Wustrow; Dirk G Brockstedt; Oezcan Talay; Paul D Kassner; Gene Cutler
Journal:  PLoS Pathog       Date:  2022-01-13       Impact factor: 6.823

2.  Differences in Immune Response During Competition and Preparation Phase in Elite Rowers.

Authors:  Daniel Alexander Bizjak; Gunnar Treff; Martina Zügel; Uwe Schumann; Kay Winkert; Marion Schneider; Dietmar Abendroth; Jürgen Michael Steinacker
Journal:  Front Physiol       Date:  2021-12-17       Impact factor: 4.566

3.  5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas.

Authors:  Jiheng Zhang; Nan Wang; Jiasheng Wu; Xin Gao; Hongtao Zhao; Zhihui Liu; Xiuwei Yan; Jiawei Dong; Fang Wang; Yixu Ba; Shuai Ma; Jiaqi Jin; Jianyang Du; Hang Ji; Shaoshan Hu
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 7.561

4.  Murine precursors to type 1 conventional dendritic cells induce tumor cytotoxicity and exhibit activated PD-1/PD-L1 pathway.

Authors:  Megan S Molina; Emely A Hoffman; Jessica Stokes; Nicole Kummet; Richard J Simpson; Emmanuel Katsanis
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

Review 5.  The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies.

Authors:  Yaqi Wang; Shengxiang Xiao; Yumin Xia; Huixia Wang
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-20       Impact factor: 10.817

6.  Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.

Authors:  Zhuoyang Fan; Guowei Yang; Wei Zhang; Qian Liu; Guangqin Liu; Pingping Liu; Ligang Xu; Jianhua Wang; Zhiping Yan; Hong Han; Rong Liu; Minfeng Shu
Journal:  J Cell Mol Med       Date:  2021-10-05       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.